PEOPLE previously spoke to Ania Jastreboff M.D., PhD., an obesity medicine physician scientist at Yale, about Ozempic, Wegovy and the rebound weight gain that can occur if the medication is stopped.

The use of either prescription — which Dr. Ania Jastreboff tells PEOPLE are "nutrient-stimulated, hormone-based medications" that target the brain and affect satiety. As a result, the GLP-1 ...

The most common side effects with Ozempic are nausea and diarrhea, and sometimes it can cause vomiting or constipation, Ania Jastreboff, M.D., PhD., an obesity medicine physician scientist at Yale ...

Ania Jastreboff, M.D., PhD., an obesity medicine physician scientist at Yale University, tells PEOPLE that some patients notice a reduced craving for alcohol when on the medications.

Speaking to Dr. Ania Jastreboff the talk show host said for many years she thought that thin people had more willpower, saying: "They ate better foods. They were able to stick to it longer.

Ania Jastreboff, M.D., PhD., an obesity medicine physician scientist at Yale University, spoke to PEOPLE last year about how some patients notice a reduced craving for alcohol while using Ozempic.

In a recent episode of her podcast, the 70-year-old spoke with Dr. Ania Jastreboff about the function and safety of these drugs, and it changed her perspective on the matter. “One of the things ...

Ania Jastreboff, an obesity medicine physician scientist at Yale University, told People magazine last year that some patients noticed they had less desire to consume alcohol while taking Ozempic ...

By the year 2030, experts predict the numbers will rise to 50 percent. Dr. Ania Jastreboff, a Yale School of Medicine endocrinologist, is studying the impact of the diabetes medication tirzepatide ...